No Data
The Whole World Is Waiting for Trump to Wield the Tariff Stick. Here's What You Need to Know
Is Bristol-Myers Squibb Gaining or Losing Market Support?
The "Liberation Day" of Trump's tariffs is approaching, and the pharmaceutical Industry may not be among the targets.
According to reports, President Trump of the USA is expected to announce a series of broader tariff measures on local time April 2 (Wednesday), which will not include any specific details on Pharmaceutical tariffs.
Express News | Sources Do Not Expect Trump to Announce Pharma-Specific Tariffs Wednesday
Bristol-Myers Squibb: Hold Rating Maintained Amid Fair Valuation and Revenue Uncertainty
What kind of week will this be? Global stock markets are facing a "tariff storm," and U.S. Treasury bonds are back in focus.
Since this quarter, U.S. Treasury bonds have outperformed Stocks, with a cumulative increase of more than 2%, while the S&P 500 Index has declined by about 5%. Analysis suggests that the 'reciprocal tariff' policy may impact the stock of Industries such as Autos, chips, and Pharmaceuticals, while the outlook of economic downturn and declining stock market will continue to elevate U.S. Treasury bonds as a safe haven Assets.
103704497 : This old dog has killed many people.